I SEE YOU, reader. You drink the probiotic seltzer, with its gut-improving bacteria, and the fiber-filled prebiotic. You regularly consume eclectic fermented foods and burly amounts of kale to ...
Benjamin Oakes' Scribe Therapeutics is developing specialized Crispr proteins to tackle a wide range of diseases–and it’s garnered deals with Big Pharma potentially worth over $4 billion.
In 2013, Benjamin ...
Scientists are engineering microbes to make healthier compounds. They hope they’ll help treat disease and save the planet.
Microbes have been on my mind this week. These tiny organisms are ...
Hype springs eternal in medicine, but lately the horizon of new possibility seems almost blindingly bright. “I’ve been running my research lab for almost 30 years,” says Jennifer Doudna, ...
CRISPR pioneer Jennifer Doudna's company Scribe Therapeutics inked a major deal with Prevail Therapeutics potentially worth $1.5 billion to create genetic medicines for neurological and neuromuscular diseases. Scribe CEO ...
Scribe Therapeutics found another partner, this time with Prevail Therapeutics, a subsidiary of Eli Lilly, in a $75 million upfront deal for neuromuscular and neurological diseases.
Unlike Scribe’s ex vivo ...
Collaboration combines Scribe Therapeutics’ novel CRISPR by Design™ approach with Prevail Therapeutics’ deep expertise in developing genetic medicines for neurological disorders towards specified genetic targets
Scribe to receive ...
Deep in the bellies of cows are tiny microbes that ferment grass and hay, breaking it down into fatty acids that serve as bovine energy—and into planet-warming methane gas. ...
We sat down with some of the most curious minds in life sciences and healthcare and invited them to share their thoughts on their careers, the future of health ...
The parents of a 2-year-old girl write that their daughter “could die within the next year” because a genetic mutation is causing her heart to fail.
“Time is quickly running ...
A guide to contemporary doomsday scenarios — from the threats you know about to the ones you never think of.
And here we are at the crux of our existential ...
From the philosophers whose moral imagination pushes the boundaries of what is possible to the activists making the world a better and healthier place on the ground, from the ...
Sanofi has teamed up with Scribe Therapeutics to write the next chapter in its natural killer (NK) cell therapy story, paying $25 million upfront and committing to $1 billion ...
Scribe Therapeutics Inc., a molecular engineering company pioneering a CRISPR by Design™ platform for genetic medicine, today announced a strategic collaboration with Sanofi for the use of Scribe’s CRISPR ...
The following is an excerpt of The Atlantic opinion editorial by CRISPR co-inventor and Nobel Prize-winner Dr. Jennifer Doudna.
CRISPR is changing the world - but it can do more.
Two ...
CRISPR is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of viruses called ...
Just a decade after Crispr was invented, the first drug to make use of the revolutionary gene-editing technology will be with regulators by the end of the year, with ...
It’s entirely possible, maybe even likely, that during some slow day at the lab early in her career, Jennifer Doudna, in a moment of private ambition, daydreamed about making ...
“CRISPR-by-design” is the idea behind Scribe Therapeutics, a company spun out from Jennifer Doudna’s Nobel-winning lab that’s competing in a closely-tracked field of genome editor companies just starting to ...
Jennifer Doudna was staring at a computer screen filled with a string of As, Cs, Ts, and Gs—the letters that make up human DNA—and witnessing a debilitating genetic disease ...
On June 28, 2012, a joint press release went out from the U.S. Department of Energy and the Lawrence Berkeley National Laboratory announcing a new paper in Science from an ...
The gene-editing tool has transformed the study of human disease, but before it can revolutionize treatments, researchers will need to solve three basic problems.
Ten years ago this week, a report of ...
The gene-editing technology has led to innovations in medicine, evolution and agriculture — and raised profound ethical questions about altering human DNA.
Ten years ago this week, Jennifer Doudna and ...
New funding from the Chan Zuckerberg Initiative kickstarts CRISPR-enabled carbon removal research at the Innovative Genomics Institute
A new research program at the Innovative Genomics Institute (IGI), supported by a ...
Ever since the draft of the human genome became available in 2001, there has been a nagging question about the genome’s “dark matter”—the parts of the map that were ...
Innovative Genomics Institute Founder, Nobel Laureate, and CRISPR co-discoverer Jennifer Doudna joins Emily Chang to discuss the future of the CRISPR technology and its commercialization, as well as the ...
Sixth Street Chief Science Adviser and Nobel laureate Jennifer Doudna, co-founder of the CRISPR genome editing technology, and Sixth Street Vice Chairman and Partner R. Martin Chavez join Emily ...
New innovations in gene and stem cell technology have the power to shape ecosystems and even change humanity. In this episode of NPR's TED Radio Hour hour, Jennifer Doudna ...
According to most accounts, Doudna’s history-altering discovery started over coffee with Jillian Banfield, a University of California microbiologist who spends her field seasons knee-deep in caves and abandoned mines ...
A cup of tea in 2006 changed genetic engineering forever. Jill Banfield, a University of California at Berkeley ecosystem scientist and 1999 MacArthur Foundation fellow had become curious in ...
For more than a year, Victoria Gray's life had been transformed. Gone were the sudden attacks of horrible pain that had tortured her all her life. Gone was the ...
A new crop of biotechs is looking to either improve CRISPR or develop new gene-editing techniques — and 2022 may be a crucial year in proving their value.
For all ...
2022 will be a critical year of execution for the gene-editing technology known as CRISPR. Several biotechs are advancing into human clinical trials, and the results could show the ...
Scientists are a cautious bunch, fond of a caveat even when describing their own research. “Our favourite expressions are ‘Yes, but…’ and ‘On the other hand…’ and ‘It remains ...
Benjamin Oakes is carving out a space in the gene-editing field by developing what he calls a "genetic scalpel."
After researching gene editing in the labs of CRISPR pioneer Jennifer ...
CRISPR is the latest and most powerful technique for changing the genetic code of living things. This method of gene editing is already showing great promise in treating people ...
Gene editing has become one of biotech's hottest areas as the first-in-human results have suggested the technology holds the potential to cure certain diseases with a single treatment.
In 2021, ...
Last year, Jennifer Doudna and Emmanuelle Charpentier became the first all-woman team to win the Nobel Prize in Chemistry for their work developing CRISPR-Cas9, the gene-editing technology. The technology ...
Patrick Doherty had always been very active. He trekked the Himalayas and hiked trails in Spain.
But about a year and a half ago, he noticed pins and needles in ...
The gene editor CRISPR excels at fixing disease mutations in lab-grown cells. But using CRISPR to treat most people with genetic disorders requires clearing an enormous hurdle: getting the ...
Digital data related to Nobel Prize-winning inventions for gene editing and cancer immunotherapy will be sold connected to non-fungible tokens next week, a novel way for the University of ...
How much will someone be willing to pay for a few pages of quarter-century-old bureaucratic university paperwork that have been turned into a blockchain-encoded piece of digital art?
Berkeley announced ...
Tory Burch has helped thousands of women entrepreneurs through her eponymous foundation and its education programs, but very few recipients of her coveted one-year business fellowship have founded biotech ...
Fireside chats have become a staple of pandemic-era virtual events. The reasons are clear: they offer a glimpse into an otherwise private conversation and it’s entertaining to listen to ...
Last year, Jennifer Doudna and Emmanuelle Charpentier became the first all-woman team to win the Nobel Prize in Chemistry for their work developing CRISPR-Cas9, the gene-editing technology. The technology ...
In this latest "Bloomberg Studio 1.0," host Emily Chang sits down with CRISPR co-inventor and 2020 Nobel Prize winner, Dr. Jennifer Doudna. They discuss her groundbreaking work on DNA, ...
Ben Oakes’ dive inside the human mind colors his leadership role at gene editing startup Scribe Therapeutics.
As an undergrad, Ben Oakes wanted to learn how the mind worked — ...
Scribe Therapeutics is adding another $100 million to its coffers six months after unveiling a $20 million series A and a partnership with Biogen to work on gene editing ...
Scribe Therapeutics has completed an oversubscribed $100-million Series B financing, with aims to further develop its suite of custom gene-editing and delivery technologies based on molecular engineering, as well ...
Nearly a decade ago, when the first CRISPR companies started looking for capital, Behzad Aghazadeh passed.
Aghazadeh, one of biotech’s more opinionated investors, had invested in gene editing before, but ...
Imagine being able to change the genes responsible for causing diseases. For Scribe Therapeutics, a gene-editing company that develops genetic medicines, this is no longer a dream but a ...
The pandemic year has been marked by so much tragedy, but I am heartened by what scientific innovation and collaboration have achieved to help move our society forward.
Last March, ...
When Jennifer Doudna won the Nobel Prize for Chemistry last year, there was no black-tie ceremony in Sweden. Because of the pandemic, she picked up the medal in her backyard.
Correspondent ...
When last year’s Nobel prize for chemistry was awarded to biochemist Jennifer Doudna and microbiologist Emmanuelle Charpentier for their work in developing the technique of gene editing known as Crispr-Cas9 ...
In the spring of 2014, Jennifer Doudna had a nightmare.
The Berkeley biochemist had helped to invent a powerful new technology that made it possible to edit the human genome—an ...
In The Code Breaker, Walter Isaacson recounts the drama of the discovery in a digestible narrative that tackles the promise and the peril of Crispr.
For Isaacson, an accomplished storyteller of ...
Where do you take your career after you’ve won all of science’s biggest prizes? In this episode of Stereo Chemistry, C&EN executive editor Lisa Jarvis sits down with Nobel ...
The response to Covid-19 has been momentous but discoveries in AI, diet, conservation, space and beyond, show the power of science to improve the world post-pandemic
Genome-editing technology
This year finally ...
